Elevance Health · 1 day ago
Hemophilia Account Executive- Paragon Healthcare – Ohio
Elevance Health is a health company dedicated to improving lives and communities. The Hemophilia Account Executive is responsible for all sales activities in a specified territory, building relationships with key customers and developing territory sales forecasts and goals.
Health CareHealth InsurancePersonal HealthWellness
Responsibilities
Builds and maintains relationships with key customers of specific line of business which may include physicians, urgent care, infusion clinics, hospitals, skilled nursing centers, and payors
Works with leadership to develop territory sales forecasts and goals
Qualifies opportunities in the territory with private insurance and/or federal or state funded plans as well as potential revenue
Identifies and resolves customer service issues in territory
Assists customer service and provides necessary information to meet customer’s needs
Networks with industry partners
Partners with appropriate team members, leadership, and other principals to close deals and negotiate deliverables
Assesses and reports on competitive sales activities
Assists in the development and implementation of competitive sales strategies
Represents region appropriately in sales efforts
Qualification
Required
Requires a BA/BS degree and a minimum of 2 sales experience; or any combination of education and experience which would provide an equivalent background
Preferred
Healthcare experience strongly preferred
Hemophilia sales experience strongly preferred
Benefits
Comprehensive benefits package
Incentive and recognition programs
Equity stock purchase
401k contribution
Paid Time Off
Medical, dental, vision, short and long term disability benefits
401(k) +match
Stock purchase plan
Life insurance
Wellness programs
Financial education resources
Company
Elevance Health
Elevance Health is an integrated whole-health approach to help people in health journey and address their full range of needs.
Funding
Current Stage
Public CompanyTotal Funding
unknown2001-10-30IPO
Leadership Team
Recent News
2026-01-16
2026-01-12
2026-01-11
Company data provided by crunchbase